News for hackers. Stuff that matters.
Re:Theranos' Highly-Anticipated Defense of Its Tech Is Calle... by EpicEng on Tuesday August 02, 2016 @03:24PM (#12212574)
Perhaps, if the test offers a strategic or tactical advantage. I work in biotech on FDA regulated devices and assays. Just throwing something out there doesn't mean it has sufficient clinical utility to reach volume, and the process is very expensive.

There are no comments on this comment yet.